This study proposed that the levels of RAD51 in some cancer types depended on proliferating T cells if there is a large proportion of T cells, but for most samples, T cells have a relatively low proportion and the major expression of RAD51 was from cancer cells. The gene discussed is RAD51; the disease is cancer.